PRODUCTS
We aim to be one of the pioneers in Indonesia in producing high-grade and complex APIs with the aim of reducing the reliance of imported drugs, improving the availability of high-quality and affordable medicines that benefit patient outcomes and bring hope to families. Our development phase is split into 3 phases in which we will continuously add new products into our portfolio prioritising oncology, metabolic and antivirus products. We also are developing our own innovative drug portfolio.
Innovative Drugs
Generic Drugs
Technology
We aim to deliver solutions to support the national pharmaceutical industry with a broad spectrum of needs, from API’s to formulation technology. PT Brighgene will offer end-to-end services for the entire development journey for our partners. Supplying high-end, rare and complex generics with a total technology solution to enable our customers to quickly register and launch their products:
- Product Supply: API & Formulation
- Technology: API → Formulation
ACTIVE PHARMACEUTICAL INGREDIENTS
FORMULATION TECHNOLOGY TRANSFER
SUPPLYING TO HEALTHCARE SYSTEM
15,000+m2 plant
Advanced Manufacturing
R&D Acceleration
Commercial Partnering
Drug formulations
Complex Generics
High Quality
Locally made
Affordable